COMBATING INFECTION: Mounting a defense against Burkholderia cepacia
MARYANN GODSHALL RN, CPN, MSN

$3.95
Nursing2014
May 2005 
Volume 35  Number 5
Pages 18 - 19
 
  PDF Version Available!

ABSTRACT
Outline

  • At home in nature

  • Stopping the spread of disease

  • Protecting patients with CF

  • SELECTED WEB SITES

  • SELECTED REFERENCE

  • CAPABLE OF SURVIVING for weeks in sputum and for years in water, Burkholderia cepacia is a potentially fatal opportunistic nosocomial pathogen. Because it thrives in moisture, it has a particular affinity for the lungs of patients with cystic fibrosis (CF). But it can also infect immunocompromised people and other vulnerable patients, including those requiring intensive care or mechanical ventilation. Disease can spread person-to-person or via contact with contaminated surfaces, fluids, or droplets.

    Notoriously resistant to common antiseptics and most antibiotics, B. cepacia is difficult to eradicate. Disease transmission has been traced to B. cepacia contamination of antiseptics, including povidone-iodine and chlorohexidine-cetrimides solution, dye added to enteral feedings, mouthwash, nasal spray, and even hand lotion.

    In 2003, the Society for Healthcare Epidemiology of America issued infection control guidelines for health care workers caring for CF patients. (See Protecting patients with CF and Selected reference.) Here, I'll discuss how learning more about B. cepacia and following infection control guidelines can help protect all your patients from this disease.

    At home in nature

    Previously known as Pseudomonas cepacia, B. cepacia is a Gramnegative rod living naturally in soil, water, and plants. Because it can metabolize just about anything, it's been used to break down toxic waste in the environment. Heating and drying are the best ways to kill it.

    Nine similar but genomically distinct species make up the B. cepacia complex. These species are known as genomovars , or basic combinations of genes. Each genomovar, in turn, has various strains. Genomovar III and genomovar II are most prevalent ...

    Purchase Now !

    To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

    Not a member? Join now for Free!


    Cost:$3.95
    1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

    User name:


    Password


    Forgot your user name or password?
    2)  If you have a coupon or promotional code, enter it
    here.(If not, just click Continue.


    Digital Coupon: (optional)

    3)  Click Continue to go to the next screen, where
    you'll enter your payment details.






    jQuery UI Accordion - Default functionality

    For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

    Nursing Jobs Plus
    Featured Jobs
    Recommended CE Articles

    Debunking Three Rape Myths
    Journal of Forensic Nursing, October/December 2014
    Expires: 12/31/2016 CE:2.5 $24.95


    Drug updates and approvals: 2014 in review
    The Nurse Practitioner, 13December 2014
    Expires: 12/31/2016 CE:3 $27.95


    Can Food Processing Enhance Cancer Protection?
    Nutrition Today, September/October 2014
    Expires: 10/31/2016 CE:2 $21.95


    More CE Articles

    Subscribe to Recommended CE

    Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events